Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegylated Interferon in Acute Hepatitis C
NCT00158522Phase 3Completed
- Sponsor
- ANRS
- Start
- Feb 2003
- Primary completion
- Dec 2007
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of peginterferon alfa-2a in hepatitis C virus infection, sponsored by ANRS. Started Feb 2003; status: completed.
02
Drugs
peginterferon alfa-2a
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT00158522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00158522.